Generic Estrace is used for treating conditions due to menopause (eg, hot flashes; vaginal itching, burning, or dryness), treating vulval or vaginal atrophy, and preventing osteoporosis (brittle bones). It is also used for estrogen replacement therapy after failure of the ovaries and to relieve the symptoms of breast cancer. More info »
Just wanted to write and say that I'm VERY satisfied with my purchase. I was
skeptical at first, the price seemed too good and the shipping process too
convoluted. But I sucked it up and took the plunge, ordered 90 of the lil blue guys
and sat back to wait for packages that might never come. Happily I was SO wrong! 9
days after my order was placed I received my first batch of 30+4, and just today
(another week later) I received the remaining 60. The quality of the product is
outstanding. If you\'re sitting there, wondering whether or not you should go ahead
and make a purchase here, quit wondering! The best prices, excellent service, and a
top-notch product are all present here. Go for it!
Cycling may harm men's reproductive health reports UCLA study - Examiner.com
CBS LocalCycling may harm men's reproductive health reports UCLA studyExaminer.
Estrogen May Promote Severity of CF in Women - MedPage Today
Estrogen May Promote Severity of CF in WomenMedPage TodayEstradiol appears to drive disease severity in cystic fibrosis in women by increasing mucoid conversion of Pseudomonas aeruginosa.
Study finds moderate weight loss reduces levels of sex hormones linked to ... - EurekAlert (press release)
Daily MailStudy finds moderate weight loss reduces levels of sex hormones linked to .
Watson Confirms Lo Loestrin® Fe Patent Challenge - MarketWatch (press release)
Watson Confirms Lo Loestrin® Fe Patent ChallengeMarketWatch (press release).
Watson confirms filing of ANDA for generic version of Lo Loestrin Fe with FDA - Pharmaceutical Business Review
Watson confirms filing of ANDA for generic version of Lo Loestrin Fe with FDAPharmaceutical Business ReviewWatson Pharmaceuticals has confirmed the filing of ANDA with FDA by Watson Laboratories seeking approval to market Norethindrone Acetate/Ethinyl Estradiol and Ethinyl Estradiol and Ferrous Fumarate Tablets, 1mg/0.